Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemmerich

Showing results (371-380 of 389) with videos related to

Pageof 39
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinomaErik A Williams, Meagan Montesion, Radwa Sharaf, et al.
Nature Chemical Biology|March 11, 2020
A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugsEnrico Girardi, Adrián César-Razquin, Sabrina Lindinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 21, 2016
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKDRobert Provenzano, Anatole Besarab, Chao H Sun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 4, 2017
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in ChinaNan Chen, Jiaqi Qian, Jianghua Chen, et al.
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
European Urology Focus|June 1, 2019
Genomic Features of Metastatic Testicular Sex Cord Stromal TumorsAndrea Necchi, Gennady Bratslavsky, Oleg Shapiro, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Nature Communications|December 2, 2015
Branched-chain amino acid catabolism is a conserved regulator of physiological ageingJohannes Mansfeld, Nadine Urban, Steffen Priebe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 casesRichard S P Huang, James Haberberger, Eric Severson, et al.
European Urology|January 22, 2020
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the BladderAndrea Necchi, Russell Madison, Daniele Raggi, et al.
Pageof 39

Showing results (371-380 of 389) with videos related to

Sort By:
Pageof 39
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinomaErik A Williams, Meagan Montesion, Radwa Sharaf, et al.
Nature Chemical Biology|March 11, 2020
A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugsEnrico Girardi, Adrián César-Razquin, Sabrina Lindinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 21, 2016
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKDRobert Provenzano, Anatole Besarab, Chao H Sun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 4, 2017
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in ChinaNan Chen, Jiaqi Qian, Jianghua Chen, et al.
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
European Urology Focus|June 1, 2019
Genomic Features of Metastatic Testicular Sex Cord Stromal TumorsAndrea Necchi, Gennady Bratslavsky, Oleg Shapiro, et al.
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Nature Communications|December 2, 2015
Branched-chain amino acid catabolism is a conserved regulator of physiological ageingJohannes Mansfeld, Nadine Urban, Steffen Priebe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 casesRichard S P Huang, James Haberberger, Eric Severson, et al.
European Urology|January 22, 2020
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the BladderAndrea Necchi, Russell Madison, Daniele Raggi, et al.
Pageof 39